Zoznam všetkých zadávateľov
Zobrazuji zprávy od zadavatele: Thomas Felzmann
Nalezeno zpráv: 1
New cancer vaccine developed by the Viennese high tech company Trimed Biotech * AOP Orphan invests in Trimed Biotech: together an individualised treatment concept for cancer shall be developed
Zadavatel: Thomas Felzmann
Nalezeno zpráv: 1